Medullary Thyroid Carcinoma and Clinical Outcomes in Heterozygous Carriers of the RETK666N Germline Pathogenic Variant

By sjmartinez • February 18, 2025

Yip AT, Kim TH, Peluso EM, Jacobsen SE, Yeh MW, Lechner MG. Medullary Thyroid Carcinoma and Clinical Outcomes in Heterozygous Carriers of the RET K666N Germline Pathogenic Variant. JCEM Case Rep. 2025 Feb 17;3(3):luaf002. doi: 10.1210/jcemcr/luaf002. PMID: 39963300; PMCID: PMC11831074.

Tags: Endocrinology, germline, medullary thyroid carcinoma, MEN2, pathogenic variant, Publications, RET K666N

Population-Level Teleretinal Screening Bulk Orders to Improve Diabetic Retinopathy Screening Rates: A Randomized Quality Improvement Trial

Takimoto SW, Freeby M, Han M, Vangala S, Fujimoto J, Dermenchyan A, Lambrechts S. Population-Level Teleretinal Screening Bulk Orders to Improve Diabetic Retinopathy Screening Rates:[...]

Body composition changes during cardiac rehabilitation and long-term cardiovascular outcomes in patients with coronary artery disease

Kumar A, Van C, Shahrvini T, Srikanthan P, Horwich TB. Body composition changes during cardiac rehabilitation and long-term cardiovascular outcomes in patients with coronary artery[...]

Considerations and best practices for respirometry

Ball AB, Stiles L, Divakaruni AS. Considerations and best practices for respirometry. Cell Metab. 2026 Jun 2;38(6):1093-1096. doi: 10.1016/j.cmet.2026.05.001. PMID: 42229405.